Specialized Medical Company (TADAWUL:4019)

TADAWUL:4019 Ratios and Metrics

Market cap in millions SAR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	4,800	4,510	-	-	-	-
Enterprise Value	5,377	5,124	-	-	-	-
Last Close Price	19.20	17.24	-	-	-	-
PE Ratio	18.03	16.94	-	-	-	-
Forward PE	-	16.82	-	-	-	-
PS Ratio	3.12	2.93	-	-	-	-
PB Ratio	4.04	3.80	-	-	-	-
P/TBV Ratio	4.04	3.80	-	-	-	-
P/FCF Ratio	21.03	19.76	-	-	-	-
P/OCF Ratio	14.87	13.97	-	-	-	-
PEG Ratio	-	0.93	-	-	-	-
EV/Sales Ratio	3.49	3.33	-	-	-	-
EV/EBITDA Ratio	16.39	17.23	-	-	-	-
EV/EBIT Ratio	22.88	21.81	-	-	-	-
EV/FCF Ratio	23.55	22.45	-	-	-	-
Debt / Equity Ratio	0.70	0.70	1.04	1.02	1.11	1.24
Debt / EBITDA Ratio	2.52	2.52	2.71	2.85	3.52	4.93
Debt / FCF Ratio	3.62	3.62	2.98	5.37	6.99	-
Net Debt / Equity Ratio	0.49	0.49	0.93	0.96	1.08	1.22
Net Debt / EBITDA Ratio	1.94	1.94	2.67	2.98	3.92	5.91
Net Debt / FCF Ratio	2.53	2.53	2.66	5.07	6.80	-5.25
Asset Turnover	0.69	0.69	0.70	0.69	0.65	0.61
Inventory Turnover	46.35	46.35	44.21	44.30	47.31	38.29
Quick Ratio	1.30	1.30	0.67	0.79	0.70	0.66
Current Ratio	1.42	1.42	0.76	0.87	0.76	1.12
Return on Equity (ROE)	26.42%	26.42%	22.15%	21.40%	14.54%	8.29%
Return on Assets (ROA)	6.61%	6.61%	7.00%	6.77%	4.29%	2.50%
Return on Invested Capital (ROIC)	13.36%	13.66%	13.54%	13.02%	8.06%	4.66%
Return on Capital Employed (ROCE)	12.70%	12.70%	18.10%	15.70%	10.30%	5.30%
Earnings Yield	5.55%	5.90%	-	-	-	-
FCF Yield	4.76%	5.06%	-	-	-	-
Payout Ratio	-	-	107.98%	35.57%	48.56%	62.54%
Buyback Yield / Dilution	-	-	-194.12%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.